Bottom line
What is MRVSX's expense ratio?
MRVSX's expense ratio is 1.75%, or about $175 a year on every $10,000 invested. That is more expensive than 90% of small-cap funds we track (median 0.99%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Oct 26, 2026
MRVSX fee table
| Net expense ratio | 1.75% |
|---|---|
| Gross expense ratio | 1.93% |
| Management fee | 0.86% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.57% |
| Fee waiver / reimbursement | -0.18% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Oct 26, 2026
What MRVSX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| MRVSX | $178 | $589 | $1,025 | $2,239 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.75% expense ratio costs roughly $90,800 in lost growth, versus about $54,900 for the median small-cap fund (0.99%).